Insiders / David D. Chang, M.D., Ph.D. / Activity
Activity — David D. Chang, M.D., Ph.D.
4 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | Sell | ALLO Allogene Therapeutics, Inc. Common Stock | $171.5K | -95K -1.80% | 5,185,862 1.50% of shares | medium |
| Mar 16, 2026 | Sell | ALLO Allogene Therapeutics, Inc. Common Stock | $118.0K | -48K -0.92% | 5,150,599 1.49% of shares | medium |
| Feb 2, 2026 | Grant | ALLO Allogene Therapeutics, Inc. Restricted Stock Unit | — | +393K | 392,586 0.11% of shares | low |
| Feb 2, 2026 | Grant | ALLO Allogene Therapeutics, Inc. Stock Option (Right to buy) | — | +1.4M | 1,387,931 0.40% of shares | low |